We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$49.6M
Cap. Flow
+$31.6M
Cap. Flow %
10.41%
Top 10 Hldgs %
53.1%
Holding
96
New
25
Increased
23
Reduced
11
Closed
32

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$13.1M
2
CELG
Celgene Corp
CELG
+$12.7M
3
BAX icon
Baxter International
BAX
+$11.9M
4
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$5.63M
5
VTRS icon
Viatris
VTRS
+$5.53M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$14M
2
PFE icon
Pfizer
PFE
+$9.42M
3
EW icon
Edwards Lifesciences
EW
+$8.53M
4
MCK icon
McKesson
MCK
+$5.55M
5
MDT icon
Medtronic
MDT
+$5.02M

Sector Composition

Rank Sector Weight
1 Healthcare 78.26%
2 Financials 1.78%
3 Consumer Staples 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMS
51
DELISTED
Adamas Pharmaceuticals
ADMS
$1.7M 0.56%
+60,000
New +$1.01M
HZNP
52
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.63M 0.53%
75,000
-125,000
-63% -$2.43M
ILMN icon
53
PUT
Illumina
ILMN
$28.7B
$1.44M 0.47%
+7,710
New +$1.24M
ARIA
54
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.25M 0.41%
200,000
+75,000
+60% +$492K
IMMU
55
DELISTED
Immunomedics Inc
IMMU
$1.23M 0.4%
+400,000
New +$1.12M
ASMB icon
56
Assembly Biosciences
ASMB
$540M
$1.13M 0.37%
12,500
– –
OMED
57
CALL
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.13M 0.37%
+50,000
New +$1.02M
WOOF
58
DELISTED
VCA Inc.
WOOF
$825K 0.27%
15,000
-45,000
-75% -$2.47M
SCYX icon
59
SCYNEXIS
SCYX
$47.7M
$776K 0.26%
1,563
– –
SPNC
60
DELISTED
Spectranetics Corp
SPNC
$753K 0.25%
+50,000
New +$660K
CDMO
61
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$585K 0.19%
71,429
+21,429
+43% +$173K
GEN
62
DELISTED
Genesis Healthcare, Inc.
GEN
$347K 0.11%
100,000
-80,000
-44% -$383K
NGNE icon
63
Neurogene
NGNE
$734M
$312K 0.1%
+1,250
New +$329K
MZOR
64
DELISTED
Mazor Robotics Ltd.
MZOR
$254K 0.08%
+25,000
New +$261K
ABBV icon
65
CALL
AbbVie
ABBV
$441B
– –
-60,000
Closed -$3.26M
ARWR icon
66
Arrowhead Research
ARWR
$12.6B
– –
-125,000
Closed -$720K
DXCM icon
67
CALL
DexCom
DXCM
$33.6B
– –
-60,000
Closed -$12.9M
ELV icon
68
Elevance Health
ELV
$85.3B
– –
-100,000
Closed -$14M
ESPR
69
CALL
DELISTED
Esperion Therapeutics
ESPR
– –
-50,000
Closed -$1.18M
ESPR
70
DELISTED
Esperion Therapeutics
ESPR
– –
-50,000
Closed -$1.18M
EW icon
71
Edwards Lifesciences
EW
$53.3B
– –
-360,000
Closed -$8.53M
LRMR icon
72
Larimar Therapeutics
LRMR
$446M
– –
-3,333
Closed -$1.28M
MCK icon
73
McKesson
MCK
$104B
– –
-30,000
Closed -$5.55M
MDT icon
74
Medtronic
MDT
$115B
– –
-75,000
Closed -$5.02M
LITS
75
Lite Strategy Inc
LITS
$31.7M
– –
-16,250
Closed -$510K
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2015 Portfolio in Review

As of Q4 2015, Iguana Healthcare Management held 96 positions worth $304M, up 20% from $254M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Iguana Healthcare Management deployed $31.6M of net new capital in Q4 2015, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was Baxter International: 325,000 shares worth $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 74% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Bausch Health, an estimated $4.49M trimmed.

  • Iguana Healthcare Management's largest Q4 2015 buy was Baxter International: 325,000 shares worth $12.4M.
  • Iguana Healthcare Management added most to Cigna in Q4 2015, an estimated $13.1M increase.
  • Iguana Healthcare Management's biggest Q4 2015 reduction was Bausch Health, cutting an estimated $4.49M.
  • Iguana Healthcare Management fully exited Elevance Health in Q4 2015, selling an estimated $14M.
  • Iguana Healthcare Management's ten largest holdings make up 53% of its $304M portfolio in Q4 2015.
  • Iguana Healthcare Management opened 25 new positions and closed 32 in Q4 2015.
  • Iguana Healthcare Management's portfolio value rose 20% quarter-over-quarter to $304M.

Based on Iguana Healthcare Management's 13F filing for Q4 2015, filed 16 Feb 2016.